Two California state prisons (A and B) have very high rates of coccidioidomycosis (Valley Fever). The prison health care service sought to improve their prevention strategy by risk stratification with a newly available spherulin-based Coccidioides delayed-type hypersensitivity test. Of the 36,789 voluntarily screened inmates, 4.7% experienced adverse reactions. A positive test (8.6% of those tested) was independently associated with (1) incarceration at prisons A and B, (2) admission to prison from a Coccidioides-endemic county, (3) length of stay at prisons A and B, and (4) increasing age. These findings suggest that the test is safe and performing well at risk stratification; the prison system now restricts inmates with negative tests from prisons A and B. This novel use of the test might benefit other coccidioidomycosis prevention programs.
Centers for Disease Control and Prevention. (2013). Increase in reported coccidioidomycosis—United States, 1998–2011. Morbidity and Mortality Weekly Report, 62, 217–221.
4.
de PerioM. A., BurrG. A. (2014). Health hazard evaluation report: Evaluation of Coccidioides exposures and coccidioidomycosis infections among prison employees (NIOSH Report No. 2013-0113-3198). Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. Retrieved from https://www.cdc.gov/niosh/hhe/reports/pdfs/2013-0113-3198.pdf
5.
EdwardsP. Q., PalmerC. E. (1957). Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and to histoplasmin. Diseases of the Chest, 31, 35–60.
6.
EmmettJ. (1952). Coccidioidin sensitivity among school children in Phoenix (skin test and x-ray survey). American Journal of Public Health and the Nation’s Health, 42, 241–245.
7.
FieseM. J. (1958). Coccidioidomycosis. Springfield, IL: Charles C. Thomas.
8.
FisherF. S., BultmanM. W., JohnsonS. M., PappagianisD., ZaborskyE. (2007). Coccidioides niches and habitat parameters in the southwestern United States: A matter of scale. Annals of the New York Academy of Sciences, 1111, 47–72. doi:10.1196/annals.1406.031
9.
FlynnN. M., HoeprichP. D., KawachiM. M., LeeK. K., LawrenceR. M., GoldsteinE.…WongG. A. (1979). An unusual outbreak of windborne coccidioidomycosis. New England Journal of Medicine, 301, 358–361.
10.
GalgianiJ. N., AmpelN. M., BlairJ. E., CatanzaroA., GeertsmaF., HooverS. E., … TheodoreN. (2016). 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clinical Infectious Diseases, 63, e112–e146. doi:10.1093/cid/ciw360
11.
JohnsonR., KernermanS. M., SawtelleB. G., RastogiS. C., NielsenH. S., AmpelN. M. (2012). A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis. Mycopathologia, 174, 353–358. doi:10.1007/s11046-012-9555-6
12.
LacyG. H., SwatekF. E. (1974). Soil ecology of Coccidioides immitis at Amerindian middens in California. Applied Microbiology, 27, 379–388.
13.
MaddyK. T. (1958). The geographic distribution of Coccidioides immitis and possible ecologic implications. Arizona Medicine, 15, 178–188.
NicasM., HubbardA. (2002). A risk analysis for airborne pathogens with low infectious doses: Application to respirator selection against Coccidioides immitis spores. Risk Analysis, 22, 1153–1163.
16.
PappagianisD., EinsteinH. (1978). Tempest from Tehachapi takes toll or coccidioides conveyed aloft and afar. The Western Journal of Medicine, 129, 527–530.
PurfieldA., DeradoG., Mohle-BoetaniJ., WheelerC., ParkB. (2014). Preventing coccidioidomycosis (Valley Fever) at highly endemic prisons in California: Estimating the effect of a screening skin test to identify immune inmates. Open Forum Infectious Diseases, 1, S464. doi:10.1093/ofid/ofu052.1275
19.
SchneiderE., HajjehR. A., SpiegelR. A., JibsonR. W., HarpE. L., MarshallG. A., … WernerS. B. (1997). A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. Journal of the American Medical Association, 277, 904–908.
20.
SmithC. E., BeardR. R., RosenbergerH. G., WhitingE. G. (1946). Effect of season and dust control on coccidioidomycosis. Journal of the American Medical Association, 132, 833–838.
21.
SmithC. E., BeardR. R., WhitingE. G., RosenbergerH. G. (1946). Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. American Journal of Public Health and the Nation’s Health, 36, 1394–1402.
22.
SmithC. E., WhitingE. G., BakerE. E., RosenbergerH. G., BeardR. R., SaitoM. T. (1948). The use of coccidioidin. American Review of Tuberculosis, 57, 330–360.
23.
TarloS. M., DayJ. H., MannP., DayM. P. (1977). Immediate hypersensitivity to tuberculin. In vivo and in vitro studies. Chest, 71, 33–37.
24.
ThornerJ. E. (1941). Coccidioidomycosis: Relative values of coccidioidin and tuberculin testing among children of the San Joaquin valley. California and Western Medicine, 54, 12–15.
25.
WackE. E., AmpelN. M., SunenshineR. H., GalgianiJ. N. (2015). The return of delayed-type hypersensitivity skin testing for coccidioidomycosis. Clinical Infectious Diseases, 61, 787–791. doi:10.1093/cid/civ388
26.
WheelerC., LucasK. D., Mohle-BoetaniJ. C. (2015). Rates and risk factors for coccidioidomycosis among prison inmates, California, USA, 2011. Emerging Infectious Diseases, 21, 70–75. doi:10.3201/eid2101.140836
27.
WillettF. M., WeissA. (1945). Coccidioidomycosis in southern California: Report of a new endemic area with a review of 100 cases. Annals of Internal Medicine, 23, 349–375.
